Nystatin News
Fast Facts - Arizona Daily Wildcat
The antibiotic nystatin, which is used chiefly to treat fungal infections like thrush, is named after New York state, where it was developed. ...
Pacgen Initiates a Phase iib Clinical Trial For PAC-113 - Market Wire (press release)
This study will be a randomized, examiner-blinded, parallel design trial comparing three different doses of PAC-113 to Nystatin. Nystatin is a widely used, ...
Pacgen Presents Research Data at ACCP on Evaluation of a New Host ... - Earthtimes
This study is a randomized, examiner-blinded, parallel design trial comparing three doses of PAC-113 to Nystatin mouthrinse. The study will enroll about 200 ...
Burning sensation affects dental patients' mouths - Edwards Air Force Base
Thrush, marked by white patches in the oral cavity, may be treated with oral antifungal medications such as nystatin or fluconazole. ...
Nystatin Prophylaxis May Benefit CAPD Patients - Renal and Urology News
Oral nystatin prophylaxis may prevent antibiotic-related fungal peritonitis (AR-FP) in patients receiving continuous ambulatory peritoneal dialysis (CAPD), ...
Liquid Gold Mine - Chemical & Engineering News
... sea-sponge pursuits by licensing promising hits through Biosergen, a company he founded in 2004 to develop analogs of the antifungal compound nystatin. ...
Pacgen Announces Advances in PAC-113 Program - TMC Net
This study will be a randomized, examiner-blinded, parallel design trial comparing three different doses of PAC-113 to Nystatin. The study, expected to be ...
A number of foods have medicinal effects - FreshPlaza
Fresh garlic juice was found to be an equally powerful antifungal agent as the prescription drugs amphterician and nystatin. Garlic aids digestion by ...
Pacgen Announces Advances in PAC-113 Program - PipelineReview.com (press release)
This study will be a randomized, examiner-blinded, parallel design trial comparing three different doses of PAC-113 to Nystatin. The study, expected to be ...
Pacgen Announces Advances in PAC-113 Program - TMC Net
This study will be a randomized, examiner-blinded, parallel design trial comparing three different doses of PAC-113 to Nystatin. The study, expected to be ...
Nystatin RSS Feed